EPISODE · Oct 15, 2021 · 8 MIN
FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services
from MS News & Perspectives · host MS News Today
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads the news article, “FDA to Review ANI’s Request for Cortrophin Gel Use” and reads the column by Ed Tobias, MS Wire, “Amazon Care to Expand Company’s Reach Into Healthcare Services”.===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.https://www.mayzent.com/?utm_source=changeinrms_url&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020 ===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/ =====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/
Embed this episode
NOW PLAYING
FDA to Review ANI’s Request for Cortrophin Gel Use & Amazon Care to Expand Into Healthcare Services
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.